Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: @milestone: Shareholder Letter vs. Conference Call
Reply New Message
Back To Forum List View
Icon president It must be close to Letter to the Shareholders time. eom
1
milestone
Jan 23, 2009 07:45AM

My uneducated guess is, the Conference Call replaces the Shareholder Letter, at least this month and maybe until the next 10K...but a good question I can ask PTSC's IR.

GLTY

Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply